TCL Archive Harkin, Specter Propose A $5.2-Billion Supplement For NIH. Senate Report Says NIH Funding At “Crisis Point.” July 18, 2008
TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010
TCL Archive NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted March 19, 1976
